compound 23 [PMID: 35944849]   Click here for help

GtoPdb Ligand ID: 12208

Compound class: Synthetic organic
Comment: Compound 23 is a selective cathepsin K inhibitor [2]. Cathepsin K (a collagenase) is upregulated in osteoclasts, chondrocytes and synoviocytes in osteoarthritic (OA) diseases, so inhibiting this cysteine protease would be expected to reduce/delay cartilage/subchondral bone destruction in OA joints [1]. Compound 23 is active in vitro and target engagement has been demonstrated in vivo.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 124.68
Molecular weight 562.66
XLogP 4.67
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#CC1(CC1)NC(=O)[C@@H]1CCCC[C@H]1c1oc(nc1c1ccc(cc1)N1CCS(=O)(=O)CC1)c1ccc(cc1)F
Isomeric SMILES Fc1ccc(cc1)c1nc(c(o1)[C@@H]1CCCC[C@H]1C(=O)NC1(CC1)C#N)c1ccc(cc1)N1CCS(=O)(=O)CC1
InChI InChI=1S/C30H31FN4O4S/c31-22-9-5-21(6-10-22)29-33-26(20-7-11-23(12-8-20)35-15-17-40(37,38)18-16-35)27(39-29)24-3-1-2-4-25(24)28(36)34-30(19-32)13-14-30/h5-12,24-25H,1-4,13-18H2,(H,34,36)/t24-,25-/m1/s1
InChI Key SBWFYUHMCHTQJT-JWQCQUIFSA-N
References
1. Deaton DN, Tavares FX. (2005)
Design of cathepsin K inhibitors for osteoporosis.
Curr Top Med Chem, 5 (16): 1639-75. [PMID:16375747]
2. Ginnetti AT, Paone DV, Nanda KK, Li J, Busuek M, Johnson SA, Lu J, Soisson SM, Robinson R, Fisher J et al.. (2022)
Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis.
Bioorg Med Chem Lett, 74: 128927. [PMID:35944849]